WuXi Announces Successful Test of TruTag Drug ID
August 12, 2015 at 05:11 AM EDT
WuXi PharmaTech, China's largest CRO, and TruTag Technologies of Hawaii reported that they have successfully completed a test of TruTag's nanotechnology silica security technology in solid dose drugs. The technology, which is both inert and edible, allows a digital scan to confirm the drug's authenticity. It can also disclose the drug's manufacturing location, dosage, expiration date, supply chain data, and lot or batch number. In April 2014, WuXi's venture fund invested in TruTag. More details.... Stock Symbol: (NYSE: WX) Share this with colleagues: // //